Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Clin Cancer Res. 2019 Nov 6;26(1):71–81. doi: 10.1158/1078-0432.CCR-19-2078

Table 1.

Treatment-related adverse events occurring at any grade in ≥ 10% of patients or ≥ grade 3 in any patient

Preferred Term Any grade Grade 1/2 Grade 3 Grade 4
Any event, n (%) 10 (90.9) 10 (90.9) 1 (9.1) 1 (9.1)
Fever 9 (81.8) 8 (72.7) 1 (9.1) 0
Chills 6 (54.5) 5 (45.5) 1 (9.1) 0
Fatigue 3 (27.3) 3 (27.3) 0 0
Headaches 3 (27.3) 3 (27.3) 0 0
Anemia 2 (18.2) 2 (18.2) 0 0
Emesis 2 (18.2) 2 (18.2) 0 0
Flu-like Symptoms 2 (18.2) 2 (18.2) 0 0
Hypotension 2 (18.2) 2 (18.2) 0 0
Nausea 2 (18.2) 2 (18.2) 0 0
Myalgias 1 (9.1) 1 (9.1) 1 (9.1) 0
Neutropenia 2 (18.2) 2 (18.2) 0 1 (9.1)
Leukopenia 1 (9.1) 0 0 1 (9.1)

Toxicities are reported as per the Common Terminology Criteria for Adverse Events (CTCAE), version 4.